Key result
Heart failure presents a growing global epidemic particularly among elderly HFpEF patients lacking proven therapies.
Answers are grounded in this paper and cite their sources.
Urges new HFpEF trials in the elderly; leaves open which agents will prove effective.
Annals of the Academy of Medicine Singapore
No takes yet. Share an insight, caveat, or question.
Richards et al. (2011) conducted an editorial in Heart Failure. Heart failure presents a growing global epidemic, particularly among the elderly and those with preserved ejection fraction, for whom proven pharmacological therapies remain lacking.
Synapse has enriched 10 related papers. Consider them for comparative context: